Skip to main content

Table 3 Biochemical indicators of patients with Kawasaki disease prior treatment and posttreatment of IVIG

From: Circulating adipokines are associated with Kawasaki disease

 

Prior treatment of IVIG

Posttreatment of IVIG

t

P

CRPmg/L

81.726 ± 56.671

4.014 ± 4.678

8.424

< 0.001*

ESR mm/H

54.290 ± 26.752

41.207 ± 29.089

1.815

0.075

IL-6 pg/mL

157.145 ± 298.991

3.876 ± 3.032

2.989

0.005*

PCT ng/L

1.982 ± 4.540

0.121 ± 0.131

2.493

0.017*

HB g/L

105.486 ± 8.688

108.841 ± 10.696

−1.473

0.145

PLT *10^3/L

330.432 ± 128.981

497.694 ± 141.631

−5.278

< 0.001*

NF-proBNP pg/mL

1326.462 ± 2185.425

175.156 ± 115.665

3.199

0.003*

TG mmol/L

1.296 ± 0.844

1.565 ± 0.606

−1.239

0.220

TC mmol/L

3.057 ± 0.623

3.571 ± 1.109

−2.526

0.014*

HDL mmol/L

0.613 ± 0.240

0.740 ± 0.215

−1.841

0.071

LDL mmol/L

1.973 ± 0.562

2.343 ± 0.480

−2.177

0.035*

Apo-A1 g/L

0.655 ± 0.249

0.943 ± 0.253

−3.311

0.002*

Apo-B g/L

0.697 ± 0.202

0.681 ± 0.094

0.341

0.753

  1. *represents a significant difference between groups, which is P < 0.05